Novo Nordisk
2011-03-15T17:48:37Z
2011-03-15T17:48:37Z
Novo Nordisk receives approval for Victoza® in China
| Novo Nordisk announced today that the Chinese State Food and Drug Administration (SFDA) has approved Victoza® for the treatment of type 2 diabetes. Further information:
| |||||||||||||||||||||||||||||
| | |||||||||||||||||||||||||||||
| | | ||||||||||||||||||||||||||||